OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Systematic Dissection of the Metabolic-Apoptotic Interface in AML Reveals Heme Biosynthesis to Be a Regulator of Drug Sensitivity
Kevin Lin, Abigail Xie, Justine C. Rutter, et al.
Cell Metabolism (2019) Vol. 29, Iss. 5, pp. 1217-1231.e7
Open Access | Times Cited: 92
Kevin Lin, Abigail Xie, Justine C. Rutter, et al.
Cell Metabolism (2019) Vol. 29, Iss. 5, pp. 1217-1231.e7
Open Access | Times Cited: 92
Showing 1-25 of 92 citing articles:
An atlas of human metabolism
Jonathan L. Robinson, Pınar Kocabaş, Hao Wang, et al.
Science Signaling (2020) Vol. 13, Iss. 624
Open Access | Times Cited: 332
Jonathan L. Robinson, Pınar Kocabaş, Hao Wang, et al.
Science Signaling (2020) Vol. 13, Iss. 624
Open Access | Times Cited: 332
Cancer Metabolism and the Evasion of Apoptotic Cell Death
Aditi Sharma, Lawrence Boise, Mala Shanmugam
Cancers (2019) Vol. 11, Iss. 8, pp. 1144-1144
Open Access | Times Cited: 153
Aditi Sharma, Lawrence Boise, Mala Shanmugam
Cancers (2019) Vol. 11, Iss. 8, pp. 1144-1144
Open Access | Times Cited: 153
NRF2: KEAPing Tumors Protected
Ray Pillai, Makiko Hayashi, Anastasia‐Maria Zavitsanou, et al.
Cancer Discovery (2022) Vol. 12, Iss. 3, pp. 625-643
Open Access | Times Cited: 121
Ray Pillai, Makiko Hayashi, Anastasia‐Maria Zavitsanou, et al.
Cancer Discovery (2022) Vol. 12, Iss. 3, pp. 625-643
Open Access | Times Cited: 121
Emerging therapies in cancer metabolism
Yi Xiao, Tian‐Jian Yu, Ying Xu, et al.
Cell Metabolism (2023) Vol. 35, Iss. 8, pp. 1283-1303
Open Access | Times Cited: 91
Yi Xiao, Tian‐Jian Yu, Ying Xu, et al.
Cell Metabolism (2023) Vol. 35, Iss. 8, pp. 1283-1303
Open Access | Times Cited: 91
Role of M1-polarized tumor-associated macrophages in the prognosis of advanced ovarian cancer patients
Antonio Macciò, Giulia Gramignano, Maria Cristina Cherchi, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 137
Antonio Macciò, Giulia Gramignano, Maria Cristina Cherchi, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 137
Metabolic Plasticity of Acute Myeloid Leukemia
Johanna Kreitz, Christine Schönfeld, Marcel Seibert, et al.
Cells (2019) Vol. 8, Iss. 8, pp. 805-805
Open Access | Times Cited: 128
Johanna Kreitz, Christine Schönfeld, Marcel Seibert, et al.
Cells (2019) Vol. 8, Iss. 8, pp. 805-805
Open Access | Times Cited: 128
Dysregulated haematopoietic stem cell behaviour in myeloid leukaemogenesis
Masayuki Yamashita, Paul V. Dellorusso, Oakley C. Olson, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 7, pp. 365-382
Open Access | Times Cited: 128
Masayuki Yamashita, Paul V. Dellorusso, Oakley C. Olson, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 7, pp. 365-382
Open Access | Times Cited: 128
FeOOH@Metal–Organic Framework Core–Satellite Nanocomposites for the Serum Metabolic Fingerprinting of Gynecological Cancers
Congcong Pei, Chao Liu, You Wang, et al.
Angewandte Chemie International Edition (2020) Vol. 59, Iss. 27, pp. 10831-10835
Closed Access | Times Cited: 125
Congcong Pei, Chao Liu, You Wang, et al.
Angewandte Chemie International Edition (2020) Vol. 59, Iss. 27, pp. 10831-10835
Closed Access | Times Cited: 125
The Multifaceted Role of Heme in Cancer
Veronica Fiorito, Deborah Chiabrando, Sara Petrillo, et al.
Frontiers in Oncology (2020) Vol. 9
Open Access | Times Cited: 114
Veronica Fiorito, Deborah Chiabrando, Sara Petrillo, et al.
Frontiers in Oncology (2020) Vol. 9
Open Access | Times Cited: 114
Functional Genomics In Vivo Reveal Metabolic Dependencies of Pancreatic Cancer Cells
Xiphias Ge Zhu, Aleksey Chudnovskiy, Lou Baudrier, et al.
Cell Metabolism (2020) Vol. 33, Iss. 1, pp. 211-221.e6
Open Access | Times Cited: 96
Xiphias Ge Zhu, Aleksey Chudnovskiy, Lou Baudrier, et al.
Cell Metabolism (2020) Vol. 33, Iss. 1, pp. 211-221.e6
Open Access | Times Cited: 96
Targeting the Mevalonate Pathway in Cancer
Dennis Juarez, David A. Fruman
Trends in cancer (2021) Vol. 7, Iss. 6, pp. 525-540
Open Access | Times Cited: 93
Dennis Juarez, David A. Fruman
Trends in cancer (2021) Vol. 7, Iss. 6, pp. 525-540
Open Access | Times Cited: 93
Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia
Claudie Bosc, Estelle Saland, Aurélie Bousard, et al.
Nature Cancer (2021) Vol. 2, Iss. 11, pp. 1204-1223
Closed Access | Times Cited: 81
Claudie Bosc, Estelle Saland, Aurélie Bousard, et al.
Nature Cancer (2021) Vol. 2, Iss. 11, pp. 1204-1223
Closed Access | Times Cited: 81
Stressed to death: Mitochondrial stress responses connect respiration and apoptosis in cancer
Jacob M. Winter, Tarun Yadav, Jared Rutter
Molecular Cell (2022) Vol. 82, Iss. 18, pp. 3321-3332
Open Access | Times Cited: 65
Jacob M. Winter, Tarun Yadav, Jared Rutter
Molecular Cell (2022) Vol. 82, Iss. 18, pp. 3321-3332
Open Access | Times Cited: 65
Hematopoietic versus leukemic stem cell quiescence: Challenges and therapeutic opportunities
Eimear O’Reilly, Hojjat Alizadeh Zeinabad, Éva Szegezdi
Blood Reviews (2021) Vol. 50, pp. 100850-100850
Open Access | Times Cited: 56
Eimear O’Reilly, Hojjat Alizadeh Zeinabad, Éva Szegezdi
Blood Reviews (2021) Vol. 50, pp. 100850-100850
Open Access | Times Cited: 56
The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways
Maryam Bakhtiyari, Mahsa Liaghat, Fatemeh Aziziyan, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 30
Maryam Bakhtiyari, Mahsa Liaghat, Fatemeh Aziziyan, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 30
Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AML
Yongping Zhang, Shuting Jiang, Fuhong He, et al.
Genome biology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 23
Yongping Zhang, Shuting Jiang, Fuhong He, et al.
Genome biology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 23
Construction of a Plasmonic Chip for Metabolic Analysis in Cervical Cancer Screening and Evaluation
Weikang Shu, You Wang, Chao Liu, et al.
Small Methods (2019) Vol. 4, Iss. 4
Closed Access | Times Cited: 64
Weikang Shu, You Wang, Chao Liu, et al.
Small Methods (2019) Vol. 4, Iss. 4
Closed Access | Times Cited: 64
Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancer
Kevin Lin, Justine C. Rutter, Abigail Xie, et al.
Nature Genetics (2020) Vol. 52, Iss. 4, pp. 408-417
Open Access | Times Cited: 63
Kevin Lin, Justine C. Rutter, Abigail Xie, et al.
Nature Genetics (2020) Vol. 52, Iss. 4, pp. 408-417
Open Access | Times Cited: 63
The mitochondrial carrier SFXN1 is critical for complex III integrity and cellular metabolism
Michelle Grace Acoba, Ebru S. Selen Alpergin, Santosh Renuse, et al.
Cell Reports (2021) Vol. 34, Iss. 11, pp. 108869-108869
Open Access | Times Cited: 41
Michelle Grace Acoba, Ebru S. Selen Alpergin, Santosh Renuse, et al.
Cell Reports (2021) Vol. 34, Iss. 11, pp. 108869-108869
Open Access | Times Cited: 41
Exploring the Metabolic Landscape of AML: From Haematopoietic Stem Cells to Myeloblasts and Leukaemic Stem Cells
Yashar Mesbahi, Toby N. Trahair, Richard B. Lock, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 31
Yashar Mesbahi, Toby N. Trahair, Richard B. Lock, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 31
Acute myeloid leukemia resistant to venetoclax-based therapy: What does the future hold?
Prajwal Dhakal, Melissa L. Bates, Michael H. Tomasson, et al.
Blood Reviews (2022) Vol. 59, pp. 101036-101036
Closed Access | Times Cited: 30
Prajwal Dhakal, Melissa L. Bates, Michael H. Tomasson, et al.
Blood Reviews (2022) Vol. 59, pp. 101036-101036
Closed Access | Times Cited: 30
Differential redox-regulation and mitochondrial dynamics in normal and leukemic hematopoietic stem cells: A potential window for leukemia therapy
Katharina Mattes, Edo Vellenga, Hein Schepers
Critical Reviews in Oncology/Hematology (2019) Vol. 144, pp. 102814-102814
Open Access | Times Cited: 50
Katharina Mattes, Edo Vellenga, Hein Schepers
Critical Reviews in Oncology/Hematology (2019) Vol. 144, pp. 102814-102814
Open Access | Times Cited: 50
CRISPR-cas9: a powerful tool towards precision medicine in cancer treatment
Hui Xing, Linghua Meng
Acta Pharmacologica Sinica (2019) Vol. 41, Iss. 5, pp. 583-587
Open Access | Times Cited: 46
Hui Xing, Linghua Meng
Acta Pharmacologica Sinica (2019) Vol. 41, Iss. 5, pp. 583-587
Open Access | Times Cited: 46
Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia
Lucille Stuani, Marie Sabatier, Jean‐Emmanuel Sarry
BMC Biology (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 45
Lucille Stuani, Marie Sabatier, Jean‐Emmanuel Sarry
BMC Biology (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 45
Mammary epithelial cells have lineage-rooted metabolic identities
Mathepan Mahendralingam, Hye‐Yeon Kim, Curtis W. McCloskey, et al.
Nature Metabolism (2021) Vol. 3, Iss. 5, pp. 665-681
Open Access | Times Cited: 37
Mathepan Mahendralingam, Hye‐Yeon Kim, Curtis W. McCloskey, et al.
Nature Metabolism (2021) Vol. 3, Iss. 5, pp. 665-681
Open Access | Times Cited: 37
